В здравом уме и твердой памяти. Программа профилактики болезни Альцгеймера

Hooshmand. B., et al. “Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.” Neurology 75 (2010): 1408–14.

Riggs, K. M., et al. “Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study.” Am J Clin Nutr 63 (1996): 306–14

Smith, A. D., et al. “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.” PLoS One 5 (2010): e12244.

Politis, A., et al. “Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production.” J Alzheimers Dis 19 (2010): 481–88.

Iwamoto, J., et al. “Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer’s disease.” Aging Clin Exp Res 21 (2009): 277–81.

Annweiler, C., et al. “Vitamin D and ageing: neurological issues.” Neuropsychobiology 62 (2010): 139–50.

Llewellyn, D. J., et al. “Vitamin D and risk of cognitive decline in elderly persons.” Arch Intern Med 170 (2010): 1135–41.

Annweiler, C., et al. “Dietary intake of vitamin D and cognition in older women: a large population-based study.” Neurology 75 (2010): 1810–16.

Sano, M., et al. “A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease.” N Engl J Med. 336 1997: 1216–22.

Miller, E. R., et al. “Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality.” Ann Int Med 142 (2005): 37–46.

Devore, E. E., et al. “Dietary antioxidants and long-term risk of dementia.” Arch Neurol 67 (2010): 819–25.

Gray, S. L., et al. “Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults.” J Am Geriatr Soc 56 (2008): 291–95.

DeKosky, S. T., et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial.” JAMA 300 (2008): 2253–62.

Lopez, L. B., et al. “High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study.” J Nutr Health Aging 15 (2011): 25–31.

Quinn, J. F., et al. “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.” JAMA 304 (2010): 1903–11.

Scholey, A., et al. “Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo- controlled, crossover study.” Psychopharmacology 212 (2010): 345–56.

Geng, J., et al. “Ginseng for cognition.” Cochrane Database Syst Rev 8 Dec 2010. 12:CD007769.

Small, G. W. “Alzheimer’s disease and other dementing disorders,” in Comprehensive Textbook of Psychiatry, 9th ed., B. J. and V. A. Sadock, eds. Williams & Wilkins (Baltimore: 2009), pp. 4058–65.

Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.

Schneider, L. S., et al. “Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer’s Disease Neuroimaging Initiative.” Arch Neurol 68 (2011): 58–66.

Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD), 2008.

Ferris, S., et al. “A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).” Int J Geriatr Psychiatry 22 (2007): 448–55.

Nixon, R. A., and D. S. Yang. “Autophagy failure in Alzheimer’s disease: locating the primary defect.” Neurobiol Dis 3 Feb 2011.

Nelson, L. D., et al. “PET of brain amyloid and tau in adults with Down syndrome.” Arch Neurol 68 (2001): 768–74.

Lu, P. H., et al. “Donepezil delays progression to AD in MCI subjects with depressive symptoms.” Neurology 72 (2009): 2115–21.

Mayberg, H. S. “Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment.” Br Med Bull 65 (2003): 19–207.

Глава 9

Lally, P., et al. “How are habits formed: Modelling habit formation in the real world.” Eur J Soc Psychol 2010; 40: 998–1009.

Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.

Lang, P. J., et al. “Emotion, motivation, and anxiety: Brain mechanisms and psychophysiology.” Biol Psychiatry 44 (1998): 1248–63.

Savine, A. C., and T. S. Braver. “Motivated cognitive control: reward incentives modulate preparatory neural activity during task-switching.” J Neurosci 30 (2010): 10, 294–305.